Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Interstitial Cystitis (Painful Bladder Syndrome Bladder Pain Syndrome) - Global Clinical Trials Review, 2022
... overview of Interstitial Cystitis (Painful Bladder Syndrome Bladder Pain Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Interstitial Cystitis (Painful Bladder Syndrome Bladder Pain Syndrome). Report includes ... Read More
-
Alcohol Addiction - Global Clinical Trials Review, 2022
... data relating to the clinical trials on Alcohol Addiction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Trigeminal Neuralgia (Tic Douloureux) - Global Clinical Trials Review, 2022
... scenario. This report provides top line data relating to the clinical trials on Trigeminal Neuralgia (Tic Douloureux). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Friedreich Ataxia - Global Clinical Trials Review, 2022
... data relating to the clinical trials on Friedreich Ataxia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Childhood Epilepsy Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
... 27 drugs in the pipeline with 79% molecules present in early stage. Mid-sized Pharma dominates R&D in this indication. The increasing uptake of recently launched therapies will drive the market's growth, but wide availability of ... Read More
-
Clinical Trials Market by Phase (Phase I, II, III), Service Type (Site Identification, Laboratory Services, Decentralized Clinical Trial), Therapy Area (Oncology, Infectious Disease), and Application (Vaccines, Cell & Gene Therapy) - Global Forecast to 2026
... The clinical trials market is projected to reach USD 52.0 billion by 2026 from USD 38.7 billion in 2021, at a CAGR of 6.1% during the forecast period, owing to increasing number of clinical trials, ... Read More
-
IDC PlanScape: Leveraging Real-World Data Monetization Models for Life Sciences
... real-world data, understand the different data monetization models offered, identify the key stakeholders involved, and choose the right partners and pricing and business models so as to maximize the return on investment from the data ... Read More
-
Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030
... genetic condition and is the most common cause of inherited learning disability. FXS is caused by expansion of a cytosine, guanine, and guanine (CGG) trinucleotide repeats in the 5’ untranslated region of the fragile X ... Read More
-
In Silico Clinical Trials Market Size, Share & Trends Analysis Report By Therapeutic Area (Oncology, Infectious Diseases), By Phase (Phase I, II, III), By Industry (Medical Devices, Pharmaceutical), And Segment Forecasts, 2022 - 2030
... over the forecast period, according to a new report by Grand View Research, Inc. Traditional clinical trials require huge expenditure to conduct research. Moreover, a high number of drugs and medical devices fail in the ... Read More
-
2022 Global: Eclinical Solutions - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
2022 Global: Clinical Trial Management System - Innovative Markets Forecast (2028) report
... the period 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 ... Read More
-
2022 Global: Cognitive Assessment And Training - Innovative Markets Forecast (2028) report
... the period 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 ... Read More
-
2022 Global Forecast for Electronic Trial Master File (Etmf) Systems (2023-2028 Outlook)-High Tech & Emerging Markets Report
... over 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or ... Read More
-
United States Influenza Vaccines Market: Focus on Persons Vaccinated, Pricing, Production, Supply, Promising Influenza Vaccines, Clinical Trials, Regulatory, Reimbursement, Distribution Channel, Major Deals, Key Players, Recent Developments – Size, Share, Trends, Analysis, Demand, Opportunity, and Forecast, 2022 – 2030
... Forecast, 2022 – 2030 The United States Influenza Vaccines market size is expected to reach USD 7,007 million by 2030. It is expected to expand at a CAGR of 6.9% from 2021 to 2030. This ... Read More
-
Healthcare Cold Chain Monitoring Market: Information by Component (Hardware (Sensors, Data Loggers, Real-Time Monitoring Devices, RFID Devices, Resistance Temperature Detectors, and Others), Software (Cloud Based and On-Premises),Temperature Type (Frozen and Chilled), Product (Vaccines, Biopharmaceuticals, Clinical Trial Materials, and Others),End-User (Biopharmaceutical Companies, Hospital & Clinics, Research Institutes, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027
... Trial Materials, and Others),End-User (Biopharmaceutical Companies, Hospital & Clinics, Research Institutes, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2027 Healthcare Cold Chain Monitoring Market—Forecast till 2027 Market Overview ... Read More
-
Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Antiviral drugs are prescription ... Read More
-
In-Silico Drug Discovery Market: Focus on Product, Workflow, Technology, and End User - Analysis and Forecast, 2021-2031
... - Software, Software-as-a-Service (SaaS), and Consultancy-as-a-Service Technology - Artificial Intelligence, Graphics Processing Unit (GPU), and Other Technologies Software - Molecular Modeling and De Novo Drug Design Software, Pharmacophore Modeling Software End User - Contract Research ... Read More
-
Global Neoantigen Cancer Vaccine Market: Focus on Approach, Line of Therapy, Type, Application, Treatment Strategy, and Country-Wise Analysis - Analysis and Forecast, 2024-2031
... Personalized and Off-the-Shelf Type of Neovaccine - Nucleic Acid Vaccine, Peptide Vaccine, and Dendritic Cell-Based Vaccine Therapeutic Specialty - Lung Cancer, Urinary System Cancer, Melanoma, Liver Cancer, Head and Neck Cancer, and Blood and Bone ... Read More
-
Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)
... Analysis for Novel Drug Candidates) Cancer is one of the leading causes of death, worldwide. In 2020 alone, over 19 million new cases of the disease (affecting different organs) and close 10 million associated fatalities, ... Read More
-
Pharmacovigilance Market (Drug Development: Preclinical Studies, Phase I, Phase II, Phase III, and Phase IV or Post Marketing Surveillance; Type of Methods: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining; and Type of Service: In-house and Contract Outsourcing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Mining; and Type of Service: In-house and Contract Outsourcing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 Pharmacovigilance Market – Scope of Report TMR’s report on the global pharmacovigilance market studies past ... Read More
-
Chemotherapy Induced Anemia - Market Insight, Epidemiology And Market Forecast - 2032
... the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Chemotherapy-induced anemia market report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted Chemotherapy-induced ... Read More
-
Chagas disease - Pipeline Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Chagas disease ... Read More
-
Multiple sclerosis - Pipeline Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Multiple sclerosis ... Read More
-
Acinetobacter infections - Pipeline Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Acinetobacter infections ... Read More
-
Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... PIM1 or PIM1 or EC 2.7.11.1) pipeline Target constitutes close to 16 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. The latest report SerineThreonine Protein Kinase Pim ... Read More
Research Assistance
